Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues. - Wikidata - wikimedia - TriplyDB

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

http://www.wikidata.org/entity/Q34884062

about

Glycoproteomic and glycomic databases On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging.Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Calreticulin activates β1 integrin via fucosylation by fucosyltransferase 1 in J82 human bladder cancer cells.FUT2 genetic variants as predictors of tumor development with hepatocellular carcinoma.High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma.

P2860

Q21245406-BA80EC6A-A17B-42D2-A47B-A6ED3EDE7205 Q34070244-3C284991-2D5A-4679-8B9F-B0120BFEBCB3 Q37641583-C5E9CE3D-7BA0-41EC-88B8-F0E8D88C12AD Q38833111-BC04A3AB-2F8C-4610-9E40-05E139F5ADD1 Q39018762-3321A97B-BB47-4633-A0A5-9FB6603A8557 Q41455314-B9051250-B632-4CA5-842F-9E2368687492 Q41544461-0BD574FC-0702-4BB7-89CD-4EC18935A42D

P2860

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

http://www.wikidata.org/entity/Q34884062

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

@ast

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

@en

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

@nl

type

label

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

@ast

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

@en

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

@nl

prefLabel

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

@ast

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

@en

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

@nl

P1433

Q34884062-82763E3D-2955-46E8-B5F7-1C307F8F419C

P1476

Q34884062-5BC402D9-F1FF-4B41-A0DC-D4E187DE5389

P2093

Q34884062-022923D0-BFBA-42A4-9B82-75D0FA21B068

Q34884062-09047DE2-1B06-4625-8942-DA0263199D34

Q34884062-1C875E34-27C3-4D85-B67F-04BF5480848A

Q34884062-2FAD51D6-A0BA-40AF-85D5-3D3B217D3C83

Q34884062-409AD291-951B-4733-9ADD-32CD372E80FA

Q34884062-53A2E88E-B414-4B07-B264-66A2FCDE4EEF

Q34884062-5C1544ED-F78D-4782-BC0A-CE9F46D773E9

Q34884062-95FE9899-3FB7-4004-BADE-8C8A9B639785

Q34884062-B902B122-8F7E-4C92-A183-E97765C9A8CB

Q34884062-C9C0C86D-C70D-4010-8E0E-088440F8E91B

P2860

Q34884062-0E4C037F-9F16-4936-B557-BD4E3A0334CD

Q34884062-0FD0FD3F-E342-42A2-B2F4-746DA2F11249

Q34884062-28A895BC-460C-4D9F-A3D0-84D74DD54706

Q34884062-3243A16C-5551-4F90-B01C-3961013A465B

Q34884062-395DC85D-7BF6-44C6-A160-3DD3BB357AEE

Q34884062-39F9E0FE-ED7E-4092-92B6-E6E100B9D7CF

Q34884062-3F0550DA-4D54-4E06-B1C5-9423B581981E

Q34884062-5BF4131D-260F-43DC-BB0A-3FD47844D82F

Q34884062-64534DD5-D0B3-4C78-847E-763B7A91A599

Q34884062-697FF63A-27EA-4C66-9519-47CB08970045

P304

Q34884062-D5D8F4BE-AAA8-40E4-9D29-3A6772BF6E87

P31

Q34884062-DA9C5877-8CA2-4E69-BB62-1AB5DBE72F36

P356

Q34884062-0F3F75DC-080E-42ED-ACAB-41B46A87C20C

P433

Q34884062-5709F5E3-534A-4D12-B7A1-F41CDB892CDD

P478

Q34884062-58680D6F-CE00-4F7C-902E-96A6DA43F9F7

P577

Q34884062-D2B59E7C-2195-4EA1-A6B1-6FEA68893B8D

P5875

Q34884062-2E37EF3F-0283-41E2-9761-399CFE971FDF

P698

Q34884062-73534FA5-4C96-4325-B0A7-6DC6E79DF037

P356

P1433

Liver International

P1476

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

@en

P2093

Dapeng Zhou

http://www.w3.org/2001/XMLSchema#string

David Hawke

http://www.w3.org/2001/XMLSchema#string

Haiyan Liu

http://www.w3.org/2001/XMLSchema#string

Jian Zhu

http://www.w3.org/2001/XMLSchema#string

Tingting Zhu

http://www.w3.org/2001/XMLSchema#string

Xiukun Xu

http://www.w3.org/2001/XMLSchema#string

Yanping Wang

http://www.w3.org/2001/XMLSchema#string

Yunhui Yu

http://www.w3.org/2001/XMLSchema#string

Yunsen Li

http://www.w3.org/2001/XMLSchema#string

Zheng Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Potential of immunotherapy for hepatocellular carcinoma.

Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma.

Congruent strategies for carbohydrate sequencing. 2. FragLib: an MSn spectral library

Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis.

Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients.

Detection of hepatocellular carcinoma using glycomic analysis.

Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data.

Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.

Glycosylation defining cancer malignancy: new wine in an old bottle

Roles of O-fucose glycans in notch signaling revealed by mutant mice.

P304

147-160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LIV.12265

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

254260220

http://www.w3.org/2001/XMLSchema#string

P698

23902602

http://www.w3.org/2001/XMLSchema#string